These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20706122)

  • 21. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biological information obtainable from circulating tumor cells.
    Cristofanilli M
    Breast; 2009 Oct; 18 Suppl 3():S38-40. PubMed ID: 19914540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
    Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells in solid tumor in metastatic and localized stages.
    Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
    Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
    Ma PC; Blaszkowsky L; Bharti A; Ladanyi A; Kraeft SK; Bruno A; Skarin AT; Chen LB; Salgia R
    Anticancer Res; 2003; 23(1A):49-62. PubMed ID: 12683352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interphase cytogenetics with DNA-probes for chromosome 8 to detect circulating tumor cells in breast cancer patients].
    Ghadimi BM; Uhr J; Tucker T; Heselmeyer-Haddad K; Auer G; Ried T; Becker H
    Zentralbl Chir; 2001 Nov; 126(11):922-5. PubMed ID: 11753805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating and disseminated tumor cells in the management of breast cancer.
    Ross JS; Slodkowska EA
    Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
    Theodoropoulos PA; Polioudaki H; Agelaki S; Kallergi G; Saridaki Z; Mavroudis D; Georgoulias V
    Cancer Lett; 2010 Feb; 288(1):99-106. PubMed ID: 19619935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumor cells: evolving evidence and future challenges.
    Dotan E; Cohen SJ; Alpaugh KR; Meropol NJ
    Oncologist; 2009 Nov; 14(11):1070-82. PubMed ID: 19897536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migrating and circulating breast carcinoma cells are within active phases of the cell cycle.
    Kubens BS; Feldner JC; Brandt B; Zänker KS
    Anticancer Res; 2002; 22(2A):899-903. PubMed ID: 12014669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
    Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
    Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.
    Reuben JM; Lee BN; Li C; Gao H; Broglio KR; Valero V; Jackson SA; Ueno NT; Krishnamurthy S; Hortobagyi GN; Cristofanilli M
    Breast J; 2010; 16(3):327-30. PubMed ID: 20408820
    [No Abstract]   [Full Text] [Related]  

  • 39. Case study of the morphologic variation of circulating tumor cells.
    Marrinucci D; Bethel K; Bruce RH; Curry DN; Hsieh B; Humphrey M; Krivacic RT; Kroener J; Kroener L; Ladanyi A; Lazarus NH; Nieva J; Kuhn P
    Hum Pathol; 2007 Mar; 38(3):514-9. PubMed ID: 17188328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
    Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.